Trial · NCT07899788
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Occurrence of atrial fibrillation detected after stroke (AFDAS) within 3 months post-stroke | 3 months post-stroke | Proportion of participants with AFDAS detected within 3 months after the index stroke. Define AFDAS according to the study protocol. Unit of Measure: Participants / % |
| Secondary | Occurrence of AFDAS within 12 months post-stroke | 12 months after index stroke | Proportion of participants with AFDAS detected within 12 months after the index stroke. Unit of Measure: Participants / % |
| Secondary | Time to first AFDAS detection | Up to 12 months after index stroke | Time from the index stroke to first documented detection of AFDAS. Unit of measure: Days |
| Secondary | Time to initiation of direct oral anticoagulant (DOAC) therapy | Up to 12 months after index stroke | Time from the index stroke to initiation of DOAC therapy. Specify the analysis population according to the protocol. Unit of measure: Days |
| Secondary | Occurrence of recurrent ischemic stroke within 3 months post-stroke | 3 months after the index stroke | Proportion of participants experiencing recurrent ischemic stroke within 3 months after the index stroke. Unit of measure: Participants / % |
| Secondary | Occurrence of myocardial infarction within 3 months post-stroke | 3 months after the index stroke | Proportion of participants experiencing myocardial infarction within 3 months after the index stroke. Unit of measure: Participants / % |
| Secondary | Occurrence of acute peripheral arterial occlusion within 3 months post-stroke | 3 months after the index stroke | Proportion of participants experiencing acute peripheral arterial occlusion within 3 months after the index stroke. Unit of measure: Participants / % |
| Secondary | Occurrence of recurrent ischemic stroke within 12 months post-stroke | 12 months after the index stroke | Proportion of participants experiencing recurrent ischemic stroke within 12 months after the index stroke. Unit of measure: Participants / % |
| Secondary | Occurrence of myocardial infarction within 12 months post-stroke | 12 months after the index stroke | Proportion of participants experiencing myocardial infarction within 12 months after the index stroke. Unit of measure: Participants / % |
| Secondary | Occurrence of acute peripheral arterial occlusion within 12 months post-stroke | 12 months after the index stroke | Proportion of participants experiencing acute peripheral arterial occlusion within 12 months after the index stroke. Unit of measure: |
| Secondary | Cardiovascular mortality within 3 months post-stroke | 3 months after the index stroke | Proportion of participants who die from a cardiovascular cause within 3 months after the index stroke. Unit measure: Participants / % |
| Secondary | Cardiovascular mortality within 12 months post-stroke | 12 months after the index stroke | Proportion of participants who die from a cardiovascular cause within 12 months after the index stroke. Unit of measure: Participants / % |
| Secondary | All-cause mortality within 3 months post-stroke | 3 months after the index stroke | Proportion of participants who die from any cause within 3 months after the index stroke. Unit of measure: Participants / % |
| Secondary | All-cause mortality within 12 months post-stroke | 12 months after the index stroke | Proportion of participants who die from any cause within 12 months after the index stroke. Unit of measure: Participants / % |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07899788/registered